Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype
Author
Adams, Paul
Altes, Albert
Brissot, Pierre
Butzeck, Barbara
Cabantchik, Ioav
Cançado, Rodolfo
Distante, Sonia
Evans, Patricia
Evans, Robert
Ganz, Tomas
Girelli, Domenico
Hultcrantz, Rolf
McLaren, Gordon
Marris, Ben
Milman, Nils
Nemeth, Elizabeta
Nielsen, Peter
Pineau, Brigitte
Piperno, Alberto
Porto, Graça
Prince, Dianne
Ryan, John
Sanchez, Mayka
Santos, Paulo
Swinkels, Dorine
Teixeira, Emerência
Toska, Ketil
Vanclooster, Annick
White, Desley
Contributors and Hemochromatosis International Taskforce
Publication date
2018ISSN
1936-0533
Abstract
Although guidelines are available for hereditary hemochromatosis, a high percentage of the recommendations within them are not shared between the different guidelines. Our main aim is to provide an objective, simple, brief, and practical set of recommendations about therapeutic aspects of HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype, based on the published scientific studies and guidelines, in a form that is reasonably comprehensible to patients and people without medical training. This final version was approved at the Hemochromatosis International meeting on 12th May 2017 in Los Angeles.
Document Type
Article
Document version
Published version
Language
English
Subject (CDU)
61 - Medical sciences
Keywords
Medicina
Medicine
Pages
3
Publisher
Springer Nature
Collection
12
Is part of
Hepatology International
Citation
Adams, Paul; Altes, Albert; Brissot, Pierre [et al.]. Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype. Hepatology International, 2018, 12, p. 83-86. Disponible en: <https://link.springer.com/article/10.1007/s12072-018-9855-0>. Fecha de acceso: 31 ene. 2024. DOI: 10.1007/s12072-018-9855-0
This item appears in the following Collection(s)
- Ciències de la Salut [736]
Rights
© 2018 Springer Nature